K8Y-33061-84993
3 vaccinations
2 coded responses
30 check-ins
2 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 41-45
- ZIP prefix
- 549 / WI
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-31
Dose 1 — Pfizer-BioNTech
-
2021-04-02
Registered in v-safe
-
2021-04-02
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Muscle or body aches, Fatigue or tiredness, Nausea, DiarrheaAdult check-in
-
2021-04-03
Health check-in — days 1–6 daily, dose 1Feeling: Poor · Fever · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-04
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Diarrhea · Be unable to do your normal daily activitiesAdult check-in
-
2021-04-05
Health check-in — days 1–6 daily, dose 1Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activitiesAdult check-in
- 2021-04-06
- 2021-04-08
- 2021-04-14
-
2021-04-28
Dose 2 — Pfizer-BioNTech
- 2021-04-28
- 2021-04-30
- 2021-05-01
- 2021-05-02
- 2021-05-03
- 2021-05-04
- 2021-05-05
- 2021-05-12
- 2021-05-19
- 2021-06-04
- 2021-06-09
- 2021-07-28
-
2021-10-27
Survey response — 6 months, dose 2MedDRA: Chest pain, Cough, Respiratory tract congestion — Feeling: Fair · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visitFree text: Congestion and cough with chest painMedDRA releases: 2024-11 · check-in free text available
-
2021-10-27
Report sent to call center — 6 months, dose 2Get care from a doctor or other healthcare professionalOutpatient clinic or urgent care clinic visit · 1 call case(s)
- 2021-10-29
-
2021-10-29
Call successfulParticipant prefers to complete VAERS report online
-
2022-05-03
Dose 3 — Pfizer-BioNTech
-
2022-05-07
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-08
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
-
2022-05-09
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Fever · Fatigue or tirednessAdult check-in
-
2022-05-10
Health check-in — day 7, dose 3Feeling: Fair · Fever · Chills, Fatigue or tiredness · Be unable to do your normal daily activitiesAdult check-in
- 2022-05-17
- 2022-05-24
-
2022-06-07
Survey response — day 35, dose 3MedDRA: Oropharyngeal pain — Feeling: Poor · Be unable to do your normal daily activitiesFree text: Sore throatMedDRA releases: 2024-11 · check-in free text available
- 2022-06-16
- 2022-08-02
- 2022-11-03
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-31 | Pfizer-BioNTech | |
| 2 | 2021-04-28 | Pfizer-BioNTech | |
| 3 | 2022-05-03 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 10 — 6 months, dose 2
Symptoms: Congestion and cough with chest pain
Release 11 — day 35, dose 3
Symptoms: Sore throat
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Chest pain | · | · | ✓ |
| SD | Cough | · | · | ✓ |
| SD | Oropharyngeal pain | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release